Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)
NCT ID: NCT05979506
Last Updated: 2023-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
34 participants
INTERVENTIONAL
2024-01-31
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Wraps are local treatments carried out by specialized nurses and which consist in, following a therapeutic bath, applying a large quantity of cream to the whole body, followed by an occlusion. The type of cream is adapted to the area of application: thus, an emollient cream is used for the body; a cream enriched with keratolytic active ingredients is used for the feet in the event of hyperkeratosis, and an emollient cream possibly enriched with keratolytic active ingredients is used for the scalp, followed by an exposure time under a steam helmet to remove scales. This type of care is simple to perform, but requires nursing expertise, to date, it is not carried out in standard practice in France, except in the centers of Toulouse, Bordeaux and Necker and at the thermal cure of Avène-les-Bains. However, the interest of such a treatment has never been evaluated independently, which is why in this study the investigators want to evaluate the effect of carrying out a daily treatment over 3 consecutive days, on different parameters reflecting the skin condition in the short and medium term
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wraps (body and feet) as well as scalp care
The skin care consisting of wraps (body and feet) and scalp care, will be carried out consecutively over 3 days, in the hospital (outpatient or in day/traditional hospitalization).
Cutaneous wraps
The topical treatment that will be used in this study are:
* For the body, an emollient cream with a high lipid content: Cold cream
* For the scalp and feet, an emollient preparation with keratolytic action: 10% or 30% urea, depending on the scalp and feet damage
Each of the 3 treatments (body, scalp and feet) will be carried out as follows:
* Application of different topicals all over the body and face, after taking a lukewarm therapeutic bath of 20 minutes
* Occlusion by "wrapping" the patient in a plastic film, then covering with a blanket
* After 1 hour, the unabsorbed excess cream is removed with a towel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cutaneous wraps
The topical treatment that will be used in this study are:
* For the body, an emollient cream with a high lipid content: Cold cream
* For the scalp and feet, an emollient preparation with keratolytic action: 10% or 30% urea, depending on the scalp and feet damage
Each of the 3 treatments (body, scalp and feet) will be carried out as follows:
* Application of different topicals all over the body and face, after taking a lukewarm therapeutic bath of 20 minutes
* Occlusion by "wrapping" the patient in a plastic film, then covering with a blanket
* After 1 hour, the unabsorbed excess cream is removed with a towel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a scaling or erythema score \> 6/16
* Patient with a skin discomfort score \> 3/10
* Patient having given written, free and informed consent
* Patient affiliated to a social security scheme
Exclusion Criteria
* Patient having modified his treatments for ichthyosis in the month preceding inclusion
* Patient with known intolerance or allergy to one of the topicals used in the study
* Patient unable to complete the study questionnaires
* Patient under a protection regime
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne-Marie TRANIER
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toulouse University hospital
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/21/0341
Identifier Type: -
Identifier Source: org_study_id